Physician profile
Ilyas Syed Aleem
NPI 1639558323
$53,739.09
in general payments reported to CMS, 2019-2025
5 companies · $15K in 2025
The $15K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $912 · 2021: $14K · 2022: $7,831 · 2023: $148 · 2024: $16K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $4,019 · Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,775.75 |
| Travel and Lodging | $4,019.02 |
| Food and Beverage | $1,123.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $24,528.78 | 2020-2025 | Excelsius Gps, Corridor, Excelsiusgps Robotic Navigation System |
| Orthofix Medical, INC. | $18,662.95 | 2023-2025 | Cervical-Stim, Spinal-Stim, Northstar |
| Kuros Biosciences USA, INC | $10,421.36 | 2025 | Magnetos |
| Davol INC. | $126.00 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilyas Aleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.